Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The pediatric clinical pharmacist’s contribution in the management of enzyme replacement therapies
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: MUTIARA, Rina (Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo Hospital, Pharmacy)
- Co-author(s): Rina Mutiara
BackgroundEnzyme Replacement Therapies (ERTs) are the first time in Indonesia. ERTs are on the highest of the cost charts for drugs. The availability of ERTs drugs through Special Access Scheme(SAS). The clinical pharmacist are involved in the SAS process, dispensing and monitoring.
MethodsThe study was conducted in The Child Health Department.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019